Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation

The goal of this study was to determine the clinical implications of a progressively rising serum CA-125 level in the normal (< 35 U/ml) range in ovarian cancer patients with complete response to therapy. A multi-institutional investigation was undertaken to identify patients with CA-125-producin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2003-05, Vol.89 (2), p.233-235
Hauptverfasser:	Wilder, James L, Pavlik, Edward, Straughn, John M, Kirby, Tyler, Higgins, Robert V, DePriest, Paul D, Ueland, Frederick R, Kryscio, Richard J, Whitley, Ronald J, Nagell, John van
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences CA-125 Antigen - blood Epithelial Cells - pathology Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Medical sciences Middle Aged Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - immunology Ovarian Neoplasms - diagnosis Ovarian Neoplasms - immunology Ovarian Neoplasms - therapy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The goal of this study was to determine the clinical implications of a progressively rising serum CA-125 level in the normal (< 35 U/ml) range in ovarian cancer patients with complete response to therapy. A multi-institutional investigation was undertaken to identify patients with CA-125-producing epithelial ovarian cancers who experienced progressively rising antigen levels in the normal (
ISSN:	0090-8258 1095-6859
DOI:	10.1016/S0090-8258(03)00051-9